Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity

Fungi cause disease in nearly one billion individuals worldwide. Only three classes of antifungal agents are currently available in mainstream clinical use. Emerging and drug-resistant fungi, toxicity, and drug-drug interactions compromise their efficacy and applicability. Consequently, new and impr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Duncan, Vanessa, Smith, Daniel, Simpson, Laura, Lovie, Emma, Katvars, Laura, Berge, Leon, Robertson, Jennifer, Smith, Shane, Munro, Carol, Mercer, Derry, O’Neil, Deborah
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2021
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284473/
https://ncbi.nlm.nih.gov/pubmed/34031048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02345-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados